Related Experiment Video
Updated: Jun 29, 2025
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Navigating the Gut-Cardiac Axis: Understanding Cardiovascular Complications in Inflammatory Bowel Disease
Tanya Sinha1, Zukhruf Zain2, Syed Faqeer Hussain Bokhari3
1Medical Education, Tribhuvan University, Kirtipur, NPL.
Insights
Patients with inflammatory bowel disease (IBD) have a higher risk of cardiovascular complications (CVCs) due to chronic inflammation and other factors. Lifestyle changes and targeted therapies are crucial for managing this elevated CVC risk in IBD patients.
Area of Science:
- Gastroenterology and Cardiology
- Immunology and Inflammation
Background:
- Inflammatory bowel disease (IBD) is linked to increased cardiovascular complications (CVCs).
- Chronic inflammation, genetics, and immune dysregulation contribute to CVCs in IBD patients.
- IBD medications and lifestyle factors can further elevate cardiovascular risk.
Purpose of the Study:
- To review the elevated risk of CVCs in IBD patients.
- To explore the mechanisms linking IBD and CVCs.
- To discuss risk assessment, management, and future interventions for CVCs in IBD.
Main Methods:
- Literature review and synthesis of existing research on IBD and CVCs.
- Analysis of potential etiological pathways, including inflammation, endothelial dysfunction, and gut microbiome.
- Examination of the impact of IBD medications and lifestyle factors on cardiovascular health.
Main Results:
- IBD patients exhibit a significantly higher incidence of various CVCs.
- Shared inflammatory pathways, endothelial dysfunction, and gut dysbiosis are implicated in IBD-associated CVCs.
- Corticosteroids and lifestyle factors exacerbate cardiovascular risks in IBD.
Conclusions:
- Comprehensive cardiovascular risk assessment and management are essential for IBD patients.
- Lifestyle modifications are fundamental in mitigating CVC risk.
- Future strategies may involve inflammation modulation and gut microbiome interventions, requiring further research.
Abstract:
Inflammatory bowel disease (IBD) presents a complex interplay of chronic inflammation in the gastrointestinal tract and is associated with various extraintestinal manifestations, including cardiovascular complications (CVCs). IBD patients face an elevated risk of CVCs, including coronary artery disease, heart failure, arrhythmias, stroke, peripheral artery disease, venous thromboembolism, and mesenteric ischemia, necessitating comprehensive cardiovascular risk assessment and management. The intricate interplay between chronic inflammation, genetic predisposition, environmental factors, and immune dysregulation likely contributes to the development of CVCs in IBD patients. While the exact mechanisms linking IBD and CVCs remain speculative, potential pathways may involve shared inflammatory pathways, endothelial dysfunction, dysbiosis of the gut microbiome, and traditional cardiovascular risk factors exacerbated by the chronic inflammatory state. Moreover, IBD medications, particularly corticosteroids, may impact cardiovascular health by inducing hypertension, insulin resistance, and dyslipidemia, further amplifying the overall CVC risk. Lifestyle factors such as smoking, obesity, and dietary habits may also exacerbate cardiovascular risks in individuals with IBD. Lifestyle modifications, including smoking cessation, adoption of a heart-healthy diet, regular exercise, and optimization of traditional cardiovascular risk factors, play a fundamental role in mitigating CVC risk. Emerging preventive strategies targeting inflammation modulation and gut microbiome interventions hold promise for future interventions, although further research is warranted to elucidate their efficacy and safety profiles in the context of IBD. Continued interdisciplinary collaboration, advanced research methodologies, and innovative interventions are essential to address the growing burden of CVCs in individuals living with IBD and to improve their long-term cardiovascular outcomes.
More Related Videos
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...